Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.41Last Year’s EPS
-0.5Same Quarter Last Year
Strong Buy
Based on 11 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 24, 2025
|% Change Since: -5.76%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
The earnings call demonstrated strong revenue growth and strategic advancements, particularly in system sales and Medicare coverage, but was tempered by significant net losses and potential tariff impacts.Company Guidance
During the first quarter of 2025, PROCEPT BioRobotics Corporation reported a total revenue of $69.2 million, reflecting a 55% increase compared to the first quarter of 2024. The US revenue contributed $60.3 million, showing a 50% growth year-over-year. The company sold 43 robotic systems, priced at an average of $435,000, resulting in a US installed base of 547 systems, marking a 55% growth from the previous year. Additionally, handpiece sales in the US reached 11,235 units, with a year-over-year growth of 65%, generating $38 million in revenue. The gross margin for the quarter was 63.9%, up 750 basis points from the prior year. The company maintained a net loss of $24.7 million and adjusted EBITDA loss of $15.8 million. Looking forward, PROCEPT BioRobotics anticipates full-year 2025 revenue to be approximately $323 million, with the expectation of selling around 210 new robotic systems in the US. The guidance also includes a forecast for US handpiece sales to reach approximately 52,500 units, representing a 63% increase in unit volume compared to 2024.Strong Revenue Growth
Total revenue for the first quarter of 2025 was $69.2 million, representing growth of 55% compared to the first quarter of 2024.
US System and International Revenue Performance
US revenue for the first quarter was $60.3 million, representing a 50% growth, and international revenue was $8.9 million, showing a 104% increase compared to the prior year.
Significant Increase in Handpiece Sales
11,235 handpieces were sold in the US, representing a 65% year-over-year unit growth.
Favorable Clinical Outcomes
The WATER III trial showed aquablation therapy had a 0% transfusion rate and lower rates of ejaculatory dysfunction and incontinence compared to laser enucleation.
Positive Changes in Medicare Coverage
First Coast and Novitas, two large Medicare contractors, updated LCDs to streamline access to aquablation therapy for a broader patient population.
Growing Installed Base and Strategic Partnerships
The US installed base grew to 547 systems, with 43 systems sold in Q1, and 45% of the sales associated with IDN bulk buys.
---
PRCT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
PRCT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 24, 2025 | $55.70 | $52.56 | -5.64% |
| Feb 25, 2025 | $62.71 | $68.11 | +8.61% |
| Oct 28, 2024 | $68.77 | $91.00 | +32.33% |
| Aug 01, 2024 | $62.00 | $57.38 | -7.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does PROCEPT BioRobotics (PRCT) report earnings?
PROCEPT BioRobotics (PRCT) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is PROCEPT BioRobotics (PRCT) earnings time?
PROCEPT BioRobotics (PRCT) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PRCT EPS forecast?
PRCT EPS forecast for the fiscal quarter 2025 (Q2) is -0.41.
---